Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Neuropeptides. 2015 Sep 25;55:127–135. doi: 10.1016/j.npep.2015.09.006

Figure 4. Serum levels of sFlt-1 in normal pregnancies and preeclampsia.

Figure 4

A) Serum levels of sFlt-1 measured by ELISA in normal pregnancies (NP) and preeclampsia (PE). B) Serum levels of sFlt-1 in NP and PE patients subdivided into placental PE (PLPE) and maternal PE (MTPE). C) Ratio of serum sFlt-1 to serum NPY measured by radioimmunoassay in NP and PE. D) Serum sFlt-1/NPY ratio in NP, PLPE and MTPE. Data are presented as mean and standard error of the mean (SEM). *** - p<0.001 and * - p<0.05, as compared to control (NP) by t-test; ** - p<0.01 and *#- p<0.05, as compared to control (NP) by Newman-Keuls Multiple Comparison test.